Infusystem Holdings Stock News

InfuSystem (INFU) signed a national distribution agreement with Solo-Dex for its proprietary continuous nerve block catheters

INFU surprised investors by pre-releasing disappointing FY21 results, leading to a 25% selloff in shares the same day. Nothing about INFU's long-term trajectory changed as the 4Q21 miss is understanda

Gainers: Dermata Therapeutics DRMA +35%. Innoviva (INVA) +11%. Mainz Biomed (MYNZ) +9%. Regional Health Properties RHE +9%. Envista Holdings (NVST) +8%.Losers: InfuSystem

InfuSystems Holdings (AMEX: INFU ) reported its Q4 earnings results on Thursday, February 10, 2022 at 06:00 AM. Here''s what investors need to know about the announcement. Check out this: Insiders Buy Over $43M Of 4 Stocks Earnings InfuSystems Holdings missed estimated earnings … Full story available on Benzinga.com

InfuSystem (INFU) estimates Q4 net revenues to be $26.5M (+7.3% Y/Y); FY net revenues grew 5.1% to $102.4M.Analysts consensus estimates for Q4 revenue stands at $30.08M (+21.7% Y/Y)

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2021

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022

The market dropped precipitously in January 2022, with the Russell 2000 down by nearly 10%. Like many sudden market “corrections,” this one “threw out the baby with the bath water,” meaning vi

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Winter Virtual Investor Conference on Wednesday, January 19, 2022

Key Players Covered in the Home Infusion Therapy Market Research Report are Optum, Inc., Infusystem, Option Care Health Inc., Moog Inc., CareCentrix, Inc., B. Braun Melsungen AG, Lincare Holdings Inc., Baxter, Promptcare, BriovaRx Infusion Services and other key market players. Key Players Covered in the Home Infusion Therapy Market Research Report are Optum, Inc., Infusystem, Option Care Health Inc., Moog Inc., CareCentrix, Inc., B. Braun Melsungen AG, Lincare Holdings Inc., Baxter, Promptcare, BriovaRx Infusion Services and other key market players.

InfuSystem Holdings Inc. (NYSEAMERICAN:INFU)s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.00 and traded as high as $16.83. InfuSystem shares last traded at $16.67, with a volume of 73,059 shares. Separately, Zacks Investment Research raised InfuSystem from a strong sell rating [] The post InfuSystem (NYSEAMERICAN:INFU) Shares Pass Above Two Hundred Day Moving Average of $0.00 appeared first on ETF Daily News .

InfuSystem Holdings Inc. (NYSEAMERICAN:INFU) Director Gregg Owen Lehman sold 1,292 shares of the businesss stock in a transaction on Tuesday, November 30th. The stock was sold at an average price of $17.03, for a total transaction of $22,002.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available []

InfuSystem Holdings Inc. (NYSEAMERICAN:INFU) Director Christopher R. Sansone sold 80,000 shares of the firms stock in a transaction on Monday, November 22nd. The shares were sold at an average price of $17.73, for a total transaction of $1,418,400.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. []

Weather Cooling Down, But InfuSystem Heating Up